Hookipa Pharma ^Investors

Hookipa Pharma is an innovative biotechnology company based in New York, New York, founded in 2011 The company specializes in the development of immunotherapies for the treatment of cancer and infectious diseases With a significant investment scale of $84 million, Hookipa Pharma aims to advance its proprietary technologies and bring novel therapies to market The firm is committed to leveraging its expertise in viral immunotherapy to improve patient outcomes and address unmet medical needs